NCT03324451

Brief Summary

The aim of the study is to assess the effectiveness of an intervention for insulin injection initiation based on the Transtheoretical Model (TTM) for insulin-naïve patients with type 2 diabetes mellitus (T2DM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
151

participants targeted

Target at P75+ for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 27, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
7 months until next milestone

Results Posted

Study results publicly available

September 16, 2020

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

2 years

First QC Date

August 29, 2017

Results QC Date

June 17, 2020

Last Update Submit

September 14, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Glycosylated Hemoglobin (HbA1c) Levels

    Collected from blood test to assess the Glycosylated hemoglobin (HbA1c) levels

    At baseline and 12 months after the intervention

Secondary Outcomes (4)

  • Change in Diabetes Empowerment Process

    At baseline and 12 months after the intervention

  • Change in Diabetes Distress

    At baseline and 12 months after the intervention

  • Change in Quality of Life

    At baseline and 12 months after the intervention

  • Change in Body Mass Index

    At baseline and 12 months after the intervention

Study Arms (2)

Intervention arm

EXPERIMENTAL

The arm that receives "TTM Intervention for Insulin Initiation." The intervention contains two parts: (1) individual intervention; (2) insulin injection follow-up management

Behavioral: TTM Intervention for Insulin Initiation

Control arm

PLACEBO COMPARATOR

The arm that receives usual care from the hospital that hosts the control arm. Participants in the control arm receives regular patient education.

Behavioral: Usual care

Interventions

The intervention contains two parts: (1) individual intervention; (2) insulin injection follow-up management. Different intervention strategies are applied to patients according to their stages of change.

Intervention arm
Usual careBEHAVIORAL

Regular patient education on insulin injection at the control arm hospital.

Control arm

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) diagnosed with T2DM for at least half a year; (2) aged 20-70 years old; (3) controlling diabetes only through oral medication, without previous experience in insulin injection; (4) HbA1c≧8.5% as measured more than twice in a year; (5) considered suitable and recommended by the doctor to initiate insulin injection.

You may not qualify if:

  • (1) unable to communicate with language; (2) incapable of self-administering insulin injection due to visual or muscular impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lee's clinic

Kaohsiung City, 807, Taiwan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Ruey-Hsia Wang
Organization
College of Nursing,Kaohsiung Medical University

Study Officials

  • Ruey-Hsia Wang, PhD

    Kaohsiung Medical University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patients with T2DM at a clinic in southern Taiwan are assigned to the intervention arm, whereas patients with T2DM at the endocrinology department of a hospital in northern Taiwan are placed in the control arm. Eligible patients that match the inclusion criteria are recommended by doctors to initiate insulin treatment. Research assistants will explain the objectives of this study to eligible participants. Subsequently, baseline data will be collected from participants by research assistants after the participants sign the consent forms. Afterwards, the participants in the intervention arm will receive the intervention. For the control arm, the participants will receive regular patient education originally administered at the hospital.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 29, 2017

First Posted

October 27, 2017

Study Start

March 1, 2018

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

September 16, 2020

Results First Posted

September 16, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations